2026-04-18T01:11:18Zhttps://recercat.cat/oai/request

oai:recercat.cat:10256/177152024-06-13T09:50:51Zcom_2072_453036com_2072_2054col_2072_453037

00925njm 22002777a 4500 dc Rastgoo, Mojdeh author Lemaitre, Guillaume author Massich i Vall, Joan author Morel, Olivier author Marzani, Frank author García Campos, Rafael author Meriaudeau, Fabrice author 2016-02-21 Comunicació de congrés presentada a: 3rd International Conference on Bioimaging, BIOIMAGING 2016 - Part of 9th International Joint Conference on Biomedical Engineering Systems and Technologies, BIOSTEC 2016, Roma, Italy Malignant melanoma is the most dangerous type of skin cancer, yet melanoma is the most treatable kind of cancer when diagnosed at an early stage. In this regard, Computer-Aided Diagnosis systems based on machine learning have been developed to discern melanoma lesions from benign and dysplastic nevi in dermoscopic images. Similar to a large range of real world applications encountered in machine learning, melanoma classification faces the challenge of imbalanced data, where the percentage of melanoma cases in comparison with benign and dysplastic cases is far less. This article analyzes the impact of data balancing strategies at the training step. Subsequently, Over-Sampling (OS) and Under-Sampling (US) are extensively compared in both feature and data space, revealing that NearMiss-2 (NM2) outperform other methods achieving Sensitivity (SE) and Specificity (SP) of 91.2% and 81.7%, respectively. More generally, the reported results highlight that methods based on US or combination of OS and US in feature space outperform the others http://hdl.handle.net/10256/17715 Melanoma Melanoma Enginyeria biomèdica Biomedical engineering Tackling the Problem of Data Imbalancing for Melanoma Classification